Zoetis (NYSE:ZTS) updated its FY19 earnings guidance on Tuesday. The company provided EPS guidance of $3.53-3.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.49. The company issued revenue guidance of $6.18-6.28 billion, compared to the consensus revenue estimate of $6.19 billion.Zoetis also updated its FY 2019 guidance to $3.53-3.60 EPS.
A number of brokerages have issued reports on ZTS. Craig Hallum lifted their price target on Zoetis from $114.00 to $132.00 and gave the stock a buy rating in a report on Tuesday, June 25th. Stifel Nicolaus lifted their target price on Zoetis from $110.00 to $130.00 and gave the stock a buy rating in a research report on Monday, July 22nd. Bank of America cut Zoetis from a buy rating to a neutral rating and lifted their target price for the stock from $111.00 to $120.00 in a research report on Monday, July 1st. They noted that the move was a valuation call. Guggenheim began coverage on Zoetis in a research report on Thursday, May 23rd. They set a buy rating and a $114.00 target price on the stock. Finally, BMO Capital Markets lifted their target price on Zoetis from $101.00 to $105.00 and gave the stock a market perform rating in a research report on Thursday, May 9th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company has an average rating of Buy and a consensus target price of $111.73.
ZTS opened at $112.57 on Tuesday. The business’s 50-day moving average price is $114.23. The company has a debt-to-equity ratio of 2.84, a current ratio of 4.05 and a quick ratio of 2.79. Zoetis has a one year low of $78.90 and a one year high of $117.03. The firm has a market capitalization of $55.70 billion, a PE ratio of 35.96, a P/E/G ratio of 3.18 and a beta of 0.92.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 3rd. Investors of record on Friday, July 19th will be given a $0.164 dividend. This represents a $0.66 annualized dividend and a yield of 0.58%. The ex-dividend date of this dividend is Thursday, July 18th. Zoetis’s dividend payout ratio (DPR) is presently 21.09%.
In related news, insider Kristin C. Peck sold 11,500 shares of the business’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $100.92, for a total value of $1,160,580.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Roxanne Lagano sold 29,453 shares of the business’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $101.65, for a total value of $2,993,897.45. Following the completion of the transaction, the insider now owns 58,180 shares in the company, valued at approximately $5,913,997. The disclosure for this sale can be found here. Insiders sold a total of 76,613 shares of company stock worth $7,963,366 in the last 90 days. 0.29% of the stock is currently owned by insiders.
Zoetis Company Profile
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
Featured Article: What does it mean to hold a stock in street name?
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.